CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 2,111 shares at $5.67 ($11,968)
- 4 Open-market sale Chief Patient Supply Officer sold 4,358 shares at $5.67 ($24,708)
- 4 Open-market sale Chief Executive Officer sold 9,879 shares at $5.67 ($56,009)
- 4 Open-market sale Chief Operating Officer sold 2,234 shares at $6.15 ($13,744)
- 4 Open-market sale Chief Patient Supply Officer sold 1,058 shares at $6.15 ($6,509)
- 4 Open-market sale Chief Medical Officer sold 841 shares at $6.15 ($5,174)
- 4 Open-market sale Chief Executive Officer sold 2,707 shares at $6.15 ($16,654)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Patient Supply Officer sold 1,065 shares at $5.33 ($5,674)
Page 17 of 41 · 808 filings